Literature DB >> 33316927

Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases.

Maite Martínez-Uña1, Yaiza López-Mancheño1, Carlos Diéguez2,3, Manuel A Fernández-Rojo1,4, Marta G Novelle1,2,3.   

Abstract

Since its discovery twenty-five years ago, the fat-derived hormone leptin has provided a revolutionary framework for studying the physiological role of adipose tissue as an endocrine organ. Leptin exerts pleiotropic effects on many metabolic pathways and is tightly connected with the liver, the major player in systemic metabolism. As a consequence, understanding the metabolic and hormonal interplay between the liver and adipose tissue could provide us with new therapeutic targets for some chronic liver diseases, an increasing problem worldwide. In this review, we assess relevant literature regarding the main metabolic effects of leptin on the liver, by direct regulation or through the central nervous system (CNS). We draw special attention to the contribution of leptin to the non-alcoholic fatty liver disease (NAFLD) pathogenesis and its progression to more advanced stages of the disease as non-alcoholic steatohepatitis (NASH). Likewise, we describe the contribution of leptin to the liver regeneration process after partial hepatectomy, the mainstay of treatment for certain hepatic malignant tumors.

Entities:  

Keywords:  adipose tissue; hepatocarcinoma (HCC); leptin; liver regeneration; non-alcoholic fatty liver disease (NAFLD); non-alcoholic steatohepatitis (NASH); partial hepatectomy

Mesh:

Substances:

Year:  2020        PMID: 33316927      PMCID: PMC7764544          DOI: 10.3390/ijms21249368

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  282 in total

1.  Increased circulating leptin levels in chronic alcoholism.

Authors:  J M Nicolás; J Fernández-Solà; F Fatjó; R Casamitjana; R Bataller; E Sacanella; E Tobías; E Badía; R Estruch
Journal:  Alcohol Clin Exp Res       Date:  2001-01       Impact factor: 3.455

Review 2.  Understanding the marvels behind liver regeneration.

Authors:  Anan Abu Rmilah; Wei Zhou; Erek Nelson; Li Lin; Bruce Amiot; Scott L Nyberg
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-03-28       Impact factor: 5.814

3.  Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.

Authors:  Roya Navekar; Maryam Rafraf; Aida Ghaffari; Mohammad Asghari-Jafarabadi; Manouchehr Khoshbaten
Journal:  J Am Coll Nutr       Date:  2017-04-26       Impact factor: 3.169

Review 4.  Leptin, 20 years of searching for glucose homeostasis.

Authors:  Gabriela Fernández-Formoso; Sonia Pérez-Sieira; David González-Touceda; Carlos Dieguez; Sulay Tovar
Journal:  Life Sci       Date:  2015-03-02       Impact factor: 5.037

5.  Leptin administration exacerbates thioacetamide-induced liver fibrosis in mice.

Authors:  Kai Dai; Jun-Ying Qi; De-Ying Tian
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

Review 6.  Leptin in hepatocellular carcinoma.

Authors:  Shen-Nien Wang; King-Teh Lee; Chen-Guo Ker
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

7.  Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.

Authors:  Andreas Vadarlis; Christina Antza; Dimitra Rafailia Bakaloudi; Ioannis Doundoulakis; Georgios Kalopitas; Myrto Samara; Theodoros Dardavessis; Theofanis Maris; Michail Chourdakis
Journal:  J Gastroenterol Hepatol       Date:  2020-09-10       Impact factor: 4.029

8.  Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C.

Authors:  Manuel Romero-Gómez; Victor M Castellano-Megias; Lourdes Grande; José A Irles; Marina Cruz; Marí Carmen Nogales; Juan Carlos Alcón; Antonio Robles
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

Review 9.  Nonalcoholic fatty liver disease - A multisystem disease?

Authors:  Ivana Mikolasevic; Sandra Milic; Tamara Turk Wensveen; Ivana Grgic; Ivan Jakopcic; Davor Stimac; Felix Wensveen; Lidija Orlic
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

Review 10.  The glucoregulatory actions of leptin.

Authors:  Anna M D'souza; Ursula H Neumann; Maria M Glavas; Timothy J Kieffer
Journal:  Mol Metab       Date:  2017-05-04       Impact factor: 7.422

View more
  7 in total

1.  Leptin Enhances Hepatic Fibrosis and Inflammation in a Mouse Model of Cholestasis.

Authors:  Anca D Petrescu; Stephanie Grant; Elaina Williams; Su Yeon An; Nikhil Seth; Mark Shell; Tyson Amundsen; Christopher Tan; Yusra Nadeem; Matthew Tjahja; Lancaster Weld; Christopher S Chu; Julie Venter; Gabriel Frampton; Matthew McMillin; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2021-12-08       Impact factor: 4.307

Review 2.  The Head-to-Toe Hormone: Leptin as an Extensive Modulator of Physiologic Systems.

Authors:  Monica Misch; Prasanth Puthanveetil
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

Review 3.  Current Perspectives on the Beneficial Effects of Soybean Isoflavones and Their Metabolites for Humans.

Authors:  Il-Sup Kim
Journal:  Antioxidants (Basel)       Date:  2021-06-30

Review 4.  Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown.

Authors:  Simona Alexandra Iacob; Diana Gabriela Iacob
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

5.  Hepatokine Fetuin B expression is regulated by leptin-STAT3 signalling and associated with leptin in obesity.

Authors:  Dongmei Wang; Menghua Wu; Xiaofang Zhang; Long Li; Mingzhu Lin; Xiulin Shi; Yan Zhao; Caoxin Huang; Xuejun Li
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

Review 6.  Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?

Authors:  Vera Francisco; Maria Jesus Sanz; José T Real; Patrice Marques; Maurizio Capuozzo; Djedjiga Ait Eldjoudi; Oreste Gualillo
Journal:  Biology (Basel)       Date:  2022-08-19

7.  Leptin Receptors Are Not Required for Roux-en-Y Gastric Bypass Surgery to Normalize Energy and Glucose Homeostasis in Rats.

Authors:  Mohammed K Hankir; Laura Rotzinger; Arno Nordbeck; Caroline Corteville; Ulrich Dischinger; Juna-Lisa Knop; Annett Hoffmann; Christoph Otto; Florian Seyfried
Journal:  Nutrients       Date:  2021-05-04       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.